Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | XDH | P47989 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.43 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.43 |
| ▸ | HSD17B3 | P37058 | 3/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | NQO1 | P15559 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.40 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21533705 | 0.84 | CDYL (0.46) | XDHPOLBTDP1KDM4EALDH1A1 | |
| SCHEMBL14735837 | 0.82 | NQO1 (0.55) | CYP19A1HSD17B3ALDH1A1NQO1CYP1A2 | |
| SCHEMBL24486825 | 0.81 | CYP2D6 (0.58) | XDHALKTDP1KDM4EALDH1A1 | |
| SCHEMBL4369173 | 0.79 | TDP1 (0.54) | XDHCYP19A1HSD17B3TDP1KDM4E | |
| SCHEMBL21533706 | 0.78 | MEN1 (0.45) | XDHPOLBTDP1KDM4EALDH1A1 | |
| SCHEMBL21533749 | 0.77 | MEN1 (0.42) | XDHPOLBHSD17B3TDP1KDM4E | |
| SCHEMBL21533707 | 0.77 | CYP19A1 (0.43) | XDHCYP19A1HSD17B3TDP1KDM4E | |
| SCHEMBL21171898 | 0.77 | NPC1 (0.48) | XDHCYP19A1TDP1ALDH1A1NQO1 | |
| SCHEMBL10640150 | 0.76 | HSD17B3 (0.68) | POLBCYP19A1HSD17B3KDM4EALDH1A1 | |
| SCHEMBL8372531 | 0.75 | HSD17B3 (0.62) | POLBCYP19A1HSD17B3KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11352325-B2 | Rapid fluorescence tagging of glycans and other biomolecules with enhanced MS signals | WATERS TECHNOLOGIES CORPORATION (US) | 2022-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11352325-B2 | Rapid fluorescence tagging of glycans and other biomolecules with enhanced MS signals | FUT5, FUT6, ST3GAL3 | XDH 4462/4885POLB 4498/4885CYP19A1 4617/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.